Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study-Reference-Cited by-全球学者库

Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study

Published:2020-11-25 Issue:24 Volume:133 Page:2919-2927
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Su Bin,Yao Cheng,Zhao Qing-Xia,Cai Wei-Ping,Wang Min,Lu Hong-Zhou,Chen Yuan-Yuan,Liu Li,Wang Hui,He Yun,Zheng Yu-Huang,Li Ling-Hua,Chen Jin-Feng,Yu Jian-Hua,Zhu Biao,Zhao Min,Sun Yong-Tao,Lun Wen-Hui,Xia Wei,Sun Li-Jun,Dai Li-Li,Jiang Tai-Yi,Wang Mei-Xia,Zheng Qing-Shan,Peng Hai-Yan,Wang Yao,Lu Rong-Jian,Hu Jian-Hua,Xing Hui,Shao Yi-Ming,Xie Dong,Zhang Tong,Zhang Fu-Jie,Wu Hao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference26 articles.

1. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018);Chin J Intern Med,2018

2. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel;Thompson;Ann Intern Med,2012

3. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the international antiviral society-USA panel;Gunthard;JAMA,2016

4. Advanced HIV: diagnosis, treatment, and prevention;Prabhu;Lancet HIV,2019

5. Update on the AIDS/STD epidemic in China the third quarter of 2018;Chin J AIDS STD,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerability and effectiveness of albuvirtide combined with dolutegravir for hospitalized people living with HIV/AIDS;Medicine;2023-11-10

2. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13

3. Comparison of pharmacokinetics and safety of albuvirtide in healthy subjects after intravenous drip and bolus injection;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-08-03

4. Comparison of pharmacokinetics and safety of albuvirtide in healthy subjects after intravenous drip and bolus injection;2023-04-24

5. New Promising Antimicrobials in Development and Novel Approaches for Treatment of Infections;New Antimicrobials: For the Present and the Future;2023